Abstract:Age impacts alloimmunity. Effects of aging on T‐cell metabolism and the potential to interfere with immunosuppressants have not been explored yet. Here, we dissected metabolic pathways of CD4+ and CD8+ T cells in aging and offer novel immunosuppressive targets. Upon activation, CD4+ T cells from old mice failed to exhibit adequate metabolic reprogramming resulting into compromised metabolic pathways, including oxidative phosphorylation (OXPHOS) and glycolysis. Comparable results were also observed in elderly human patients. Although glutaminolysis remained the dominant and age‐independent source of mitochondria for activated CD4+ T cells, old but not young CD4+ T cells relied heavily on glutaminolysis. Treating young and old murine and human CD4+ T cells with 6‐diazo‐5‐oxo‐l‐norleucine (DON), a glutaminolysis inhibitor resulted in significantly reduced IFN‐γ production and compromised proliferative capacities specifically of old CD4+ T cells. Of translational relevance, old and young mice that had been transplanted with fully mismatched skin grafts and treated with DON demonstrated dampened Th1‐ and Th17‐driven alloimmune responses. Moreover, DON diminished cytokine production and proliferation of old CD4+ T cells in vivo leading to a significantly prolonged allograft survival specifically in old recipients. Graft prolongation in young animals, in contrast, was only achieved when DON was applied in combination with an inhibition of glycolysis (2‐deoxy‐d‐glucose, 2‐DG) and OXPHOS (metformin), two alternative metabolic pathways. Notably, metabolic treatment had not been linked to toxicities. Remarkably, immunosuppressive capacities of DON were specific to CD4+ T cells as adoptively transferred young CD4+ T cells prevented immunosuppressive capacities of DON on allograft survival in old recipients. Depletion of CD8+ T cells did not alter transplant outcomes in either young or old recipients. Taken together, our data introduce an age‐specific metabolic reprogramming of CD4+ T cells. Targeting those pathways offers novel and age‐specific approaches for immunosuppression.

Immunological discrepancy in aged mice facilitates skin allograft survival

Study on variation characteristics of anti-donor specific antibodies in different species of sensitized mice after skin transplantation

Mouse Model Established by Early Renal Transplantation after Skin Allograft Sensitization Mimics Clinical Antibody-Mediated Rejection.

Clinical Study on Renal Transplantation in Aged Recipients:A Report of 126 Cases

Role of myeloid-derived suppressor cells in mouse pre-sensitized cardiac transplant model.

Alteration Of Innate Immunity By Donor Il-6 Deficiency In A Presensitized Heart Transplant Model

CTLA4‐Ig prolongs graft survival specifically in young but not old mice

Immune Reconstitution and Survival of Patients after Allogeneic Hematopoietic Stem Cell Transplantation from Older Donors

Effect of Allogenic Bone Marrow Mesenchymal Stem Cell Transplantation on T Cells of Old Mice

Amplification of Memory T Cells in Mice by Rejection after Skin Transplantation

Targeting age‐specific changes in CD4 + T cell metabolism ameliorates alloimmune responses and prolongs graft survival

An Immunotherapeutic Strategy for Prolonging Graft Survival in Mice.

Characterization of Regulatory Dendritic Cells That Mitigate Acute Graft-versus-Host Disease in Older Mice Following Allogeneic Bone Marrow Transplantation

Enhanced allogeneic skin-graft survival using sCD95L, sCD152, interleukin-10 and transforming growth factor-β in combination, and comparison with ciclosporin

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice

Donor Specific Tolerance for MHC Mis-Matched Murine Skin Allograft Induced by Donor Bone Marrow Transplantation with Precondition of High Dose Immunosuppressants

Thymus Reconstitution in Young and Aged Mice Is Facilitated by In Vitro-Generated Progenitor T Cells

Adoptive Transfer of IFN-γ-induced M-MDSCs Promotes Immune Tolerance to Allografts Through Inos Pathway.

Induction of Immunotolerance in Mice after Skin Allotransplantation by Subcutaneous Injection of Bone Marrow

Monocytes in allo-HSCT with aged donors secrete IL-1/IL-6/TNF to increase the risk of GVHD and damage the aged HSCs